Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

400.43

+4.11 (1.04%)

At close: Nov 4, 2026, 4:00 PM EST

395.01

-5.42 (-1.35%)

Pre-market: Nov 5, 2026, 7:47 AM EST

Madrigal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	514.64	198.69	100.02	99.92	331.55	36.27
Short-Term Investments	446.32	784.87	826.23	534.22	27.23	234.08
Cash & Short-Term Investments	960.97	983.56	926.25	634.13	358.77	270.35
Cash Growth	-13.41%	6.19%	46.07%	76.75%	32.71%	-4.86%
Accounts Receivable	227.38	134.48	53.82	-	-	-
Receivables	227.38	134.48	53.82	-	-	-
Inventory	122.59	74.84	34.07	-	-	-
Prepaid Expenses	75.37	47.8	13.79	3.15	2.6	1.34
Restricted Cash	0.81	5.09	5	-	-	-
Total Current Assets	1,387	1,246	1,033	637.28	361.37	271.68
Property, Plant & Equipment	26.81	6.44	4.59	3.27	1.2	1.65
Other Intangible Assets	7.09	7.38	4.73	-	-	-
Total Assets	1,434	1,260	1,042	640.55	362.57	273.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	61.37	48.88	43.6	28.04	23.83	21.38
Accrued Expenses	391.86	260.39	124.7	89.98	91.46	55.05
Current Portion of Leases	1.01	1.02	0.98	0.53	0.6	0.41
Total Current Liabilities	454.24	310.29	169.28	118.55	115.89	76.84
Long-Term Debt	341.28	339.88	117.57	115.48	49.29	-
Long-Term Leases	11.93	6.73	1.02	1.19	-	0.39
Total Liabilities	807.45	656.9	287.86	235.21	165.18	77.23

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	2,816	2,692	2,556	1,741	1,160	863.5
Retained Earnings	-2,187	-2,090	-1,802	-1,336	-962.66	-667.31
Comprehensive Income & Other	-1.73	0.87	0.47	0.47	-0.03	-0.08
Shareholders' Equity	626.94	602.69	754.38	405.33	197.39	196.11
Total Liabilities & Equity	1,434	1,260	1,042	640.55	362.57	273.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	354.22	347.63	119.57	117.19	49.89	0.8
Net Cash (Debt)	606.75	635.93	806.68	516.94	308.88	269.55
Net Cash Growth	-20.52%	-21.17%	56.05%	67.36%	14.59%	-4.88%
Net Cash Per Share	26.28	28.35	37.92	27.66	18.02	16.30
Filing Date Shares Outstanding	23.23	22.94	22.08	19.9	18.14	17.1
Total Common Shares Outstanding	23.22	22.84	22	19.88	18.1	17.1
Working Capital	932.87	935.48	863.65	518.73	245.48	194.85
Book Value Per Share	27.00	26.39	34.28	20.39	10.90	11.47
Tangible Book Value	619.85	595.31	749.65	405.33	197.39	196.11
Tangible Book Value Per Share	26.69	26.06	34.07	20.39	10.90	11.47

SEC Filings: 10-K · 10-Q